| Product Name | MF | CAS | Details |
|---|
| Rhosin | C20H19ClN6O | 1281870-42-5 | Details |
| ZINC05007751 | C18H12N2O3 | 591239-68-8 | Details |
| AM1241 | C22H22IN3O3 | 444912-48-5 | Details |
| BMS-191011 | C16H10ClF3N2O3 | 202821-81-6 | Details |
| WAY-661957 | C15H18ClNO3S | 899902-32-0 | Details |
| RP70676 | C25H28N4S | 136609-26-2 | Details |
| 3PO | C13H10N2O | 18550-98-6 | Details |
| 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-(1-methylethyl) 5-[(1-oxobutoxy)methyl] ester | C23H27Cl2NO6 | 2177293-82-0 | Details |
| TUG-469 | C23H23NO2 | 1236109-67-3 | Details |
| GR 125,743 | C25H28N4O2 | 148547-33-5 | Details |
| PF-3845 | C24H23F3N4O2 | 1196109-52-0 | Details |
| GRP-60367 | C21H27N3O2 | 1309241-34-6 | Details |
| Ro0335 | C21H13BrCl2FN3O4S | 867365-76-2 | Details |
| JNJ-18038683 | C26H28ClN3O7 | 851376-05-1 | Details |
| Aumitin | C24H20ClN5O | 946293-78-3 | Details |
| RAD51-IN-17 | C22H16ClN3O | 2101739-18-6 | Details |
| TT01001 | C15H19Cl2N3O2S | 1022367-69-6 | Details |
| CK1-IN-1 | C24H15F2N3 | 1784751-20-7 | Details |
| SERALUTINIB | C27H27N5O3 | 1619931-27-9 | Details |
| Finasteride Carboxaldehyde | C23H34N2O3 | 154387-61-8 | Details |
| F-15599 | C19H21ClF2N4O | 635323-95-4 | Details |
| pipequaline.HCl | C22H25ClN2 | 80221-58-5 | Details |
| MS402 | C20H19ClN2O3 | 1672684-68-2 | Details |
| MLN120B | C19H15ClN4O2 | 783348-36-7 | Details |
| AMG487 | C32H28F3N5O4 | 473719-41-4 | Details |
| HCV-IN-31 | C12H17FN6O3 | 1998705-62-6 | Details |
| SG-094 | 2922283-37-0 | Details |
| UPGL00004 | C25H26N8O2S2 | 1890169-95-5 | Details |
| TH34 | C15H16N2O2 | 2196203-96-8 | Details |
| RG 14620 | C14H8Cl2N2 | 136831-49-7 | Details |
| Imiquimod Impurity | C15H17N3 | 99010-41-0 | Details |
| Buspirone Impurity | C34H52N6O5 | 2726492-72-2 | Details |
| Olaparib Impurity | C18H16FN3O2 | 2415448-60-9 | Details |
| BYK 191023 dihydrochloride | C14H15ClN4O | 1216722-25-6 | Details |
| Letermovir Impurity | C17H14F6N2O3 | 6064-14-8 | Details |
| 2-(2,6-dichloro-3,5-dimethoxyphenyl)acetonitrile | C10H9Cl2NO2 | 869882-16-6 | Details |
| Gsk484 hydrochloride | C27H32ClN5O3 | 1652591-81-5 | Details |
| LRE1 | C12H13ClN4S | 1252362-53-0 | Details |
| PDGFR Tyrosine Kinase Inhibitor III | C27H27N5O4 | 205254-94-0 | Details |
| RS 100329 | C20H25F3N4O3 | 232953-52-5 | Details |
| RS 100329 HCL | C20H26ClF3N4O3 | 1215654-26-4 | Details |
| CCR8 antagonist 1 | C26H29N3O5S | 723304-76-5 | Details |
| ML148 | C20H21N3O | 451496-96-1 | Details |
| BRD4 Inhibitor-20 | C18H18N2O4S | 2490311-14-1 | Details |
| MPT0B014 | C19H17NO4 | 1215208-59-5 | Details |
| (Rac)-Brassinazole | C18H18ClN3O | 224047-41-0 | Details |
| Nampt activator-1 | C16H17N3O3 | 701929-65-9 | Details |
| HIF-1 inhibitor-4 | C18H19IN2O2 | 333357-56-5 | Details |
| hMAO-B-IN-4 | C20H16O2S | 1666119-75-0 | Details |
| NLRP3-IN-10 | C17H14BrFO3 | 2641826-39-1 | Details |
| ALW-II-49-7 | C21H17F3N4O2 | 1135219-23-6 | Details |
| Todralazine hydrochloride | C11H13ClN4O2 | 3778-76-5 | Details |
| CP-289503 | C30H35ClN2O2 | 1349637-14-4 | Details |
| C3a receptor agonist 1 | C27H35N3O2 | 944997-60-8 | Details |
| MMRi62 | C21H15Cl2N3O | 352693-80-2 | Details |
| Benzenepropanoicacid | C22H36O6 | 26347-98-8 | Details |
| 3 - Hydroxy - 5 - n - pentyl - 2 - cyclohexen - 1 - on | C11H18O2 | 58016-29-8 | Details |
| PF-02545920 | C25H20N4O | 898563-49-0 | Details |
| PHT-427 | C20H31N3O2S2 | 1191951-57-1 | Details |
| SD49-7 | C18H14N2O3 | 54009-54-0 | Details |
| MG149 | C22H28O3 | 1243583-85-8 | Details |
| LUN76721 | C36H24Br6N3O6P3 | 4376-72-1 | Details |
| APY0201 | C23H23N7O | 1232221-74-7 | Details |
| WAY-312778 | C18H14N4O3S | 301157-29-9 | Details |
| KA2507 | C16H14N6O2 | 1636894-46-6 | Details |
| Givinostat (ITF2357) | C24H30ClN3O5 | 732302-99-7 | Details |
| TC-DAPK 6 | C17H12N2O2 | 315694-89-4 | Details |
| THAL-SNS-032 | C40H52N8O10S2 | 2139287-33-3 | Details |
| TD-106 | C12H11N5O3 | 2250288-69-6 | Details |
| VH032 | C24H32N4O4S | 1448188-62-2 | Details |
| DBRD9 | C40H45N7O10 | 2170679-45-3 | Details |
| ASTX660 | C30H42FN5O3 | 1799328-86-1 | Details |
| dTRIM24 | C55H68N8O13S2 | 2170695-14-2 | Details |
| VB-124 | C23H23ClN2O4 | 2230186-18-0 | Details |
| BMS-P5 | C27H32N6O2 | 1550371-22-6 | Details |
| CA-4948 | C21H19N7O3 | 1801343-74-7 | Details |
| Laninamivir | C13H22N4O7 | 203120-17-6 | Details |
| RN-18 | C20H16N2O4S | 431980-38-0 | Details |
| TH-Z93 | C12H22N2O7P2 | 2260887-09-8 | Details |
| BI-2865 | C23H27N7O2S | 2937327-93-8 | Details |
| GSK215 | C50H59F3N10O6S | 2743427-26-9 | Details |
| ARV-766 | C45H54FN7O6 | 2750830-09-0 | Details |
| LeterMovir-013 | C29H28F4N4O4 | 917389-37-8 | Details |
| LeterMovir-008-R | C30H30F4N4O4 | 917389-34-5 | Details |
| 2-Propenoic acid, 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-, methyl ester, (2E)- | C30H30F4N4O4 | 1791412-04-8 | Details |
| Letermovir Impurity | C30H30F4N4O4 | 917389-29-8 | Details |
| 917389-35-6 | 917389-35-6 | Details |
| 5,6,7,8-TETRAHYDRO-4 H-CYCLOHEPTA[ D ]ISOXAZOLE-3-CARBOXYLIC ACID | C9H11NO3 | 33230-32-9 | Details |
| Acitazanolast | C9H7N5O3 | 114607-46-4 | Details |
| Tazanolast | C13H15N5O3 | 82989-25-1 | Details |
| ROCK-IN-5 | C16H11ClFN3OS | 692870-25-0 | Details |
| LP-471756 | C19H23NO2S | 413605-11-5 | Details |
| p38α inhibitor 3 | C19H20FNO | 260428-69-1 | Details |
| DC-TEADin02 | C19H17NO2S | 2380228-45-3 | Details |
| CP-447697 | C29H26ClF2N3O2S | 1092847-21-6 | Details |
| MLN120B.2 HCl | C19H16Cl2N4O2 | 1782573-78-7 | Details |
| 2(1H)-Pyridinone,4-hydroxy-5-methyl-(9CI) | C6H7NO2 | 41935-71-1 | Details |
| Merafloxacin | C19H23F2N3O3 | 91188-00-0 | Details |
| Vodobatinib | C27H20ClN3O2 | 1388803-90-4 | Details |
| CITCO | C19H12Cl3N3OS | 338404-52-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 | ||||